National Bank Of Canada Abcam PLC Transaction History

National Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$21.54 - $24.41 $4.88 Million - $5.53 Million	-226,697 Reduced 73.2%	82,995 $1.88 Million
Q2 2023 Jul 26, 2023	BUY	$12.62 - $24.47 $2.85 Million - $5.52 Million	225,460 Added 267.67%	309,692 $7.58 Million
Q1 2023 Apr 12, 2023	SELL	$12.98 - $17.1 $713 - $940	-55 Reduced 0.07%	84,232 $1.13 Million
Q4 2022 Jan 24, 2023	BUY	$13.92 - $17.0 $1.14 Million - $1.39 Million	81,615 Added 3054.45%	84,287 $0
Q3 2022 Oct 13, 2022	SELL	$13.36 - $16.75 $1,402 - $1,758	-105 Reduced 3.78%	2,672 $40,000
Q2 2022 Jul 28, 2022	BUY	$12.69 - $19.25 $14,669 - $22,253	1,156 Added 71.31%	2,777 $40,000
Q1 2022 May 05, 2022	BUY	$15.5 - $23.89 $8,308 - $12,805	536 Added 49.4%	1,621 $30,000
Q4 2021 Jan 24, 2022	BUY	$20.04 - $23.84 $21,743 - $25,866	1,085 New	1,085 $26,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.